Spruce Biosciences Relocates HQ, Hints at Officer Changes
Ticker: SPRB · Form: 8-K · Filed: Dec 15, 2025 · CIK: 1683553
| Field | Detail |
|---|---|
| Company | Spruce Biosciences, Inc. (SPRB) |
| Form Type | 8-K |
| Filed Date | Dec 15, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $40,000, $5,000, $5,500 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-changes, office-relocation
Related Tickers: SPRB
TL;DR
Spruce Bio moving HQ, watch for exec shakeups.
AI Summary
Spruce Biosciences, Inc. announced on December 11, 2025, a change in its principal executive offices to 611 Gateway Boulevard, Suite 740, South San Francisco, California. This filing also indicates potential changes related to directors, officers, and compensatory arrangements, though specific details are not provided in this excerpt.
Why It Matters
A change in principal executive offices can signal operational shifts or growth, while potential changes in officer or director compensation arrangements could impact company strategy and employee morale.
Risk Assessment
Risk Level: medium — The filing mentions potential changes in directors and officers, which can introduce uncertainty regarding company leadership and strategy.
Key Players & Entities
- Spruce Biosciences, Inc. (company) — Registrant
- 611 Gateway Boulevard, Suite 740 (location) — New Principal Executive Offices
- South San Francisco, California (location) — New Principal Executive Offices City and State
- December 11, 2025 (date) — Date of earliest event reported
FAQ
What is the new address for Spruce Biosciences, Inc.'s principal executive offices?
The new address is 611 Gateway Boulevard, Suite 740, South San Francisco, California, 94080.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is December 11, 2025.
What are the main items of disclosure in this 8-K filing?
The filing concerns the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is Spruce Biosciences, Inc.'s state of incorporation and IRS Employer Identification Number?
Spruce Biosciences, Inc. is incorporated in Delaware and its IRS Employer Identification Number is 81-2154263.
What is the telephone number for Spruce Biosciences, Inc. at its principal executive offices?
The telephone number is 415-343-5986.
Filing Stats: 749 words · 3 min read · ~2 pages · Grade level 11.9 · Accepted 2025-12-15 08:05:25
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share SPRB Nasdaq Capital Marke
- $40,000 — also receive an annual cash retainer of $40,000 for her service as a director and $5,00
- $5,000 — 0,000 for her service as a director and $5,000 for her service on the Compensation Com
- $5,500 — Compensation Committee will increase to $5,500 while her annual cash retainer for her
Filing Documents
- sprb-20251211.htm (8-K) — 53KB
- 0001193125-25-318488.txt ( ) — 170KB
- sprb-20251211.xsd (EX-101.SCH) — 32KB
- sprb-20251211_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Spruce Biosciences, Inc. Date: December 15, 2025 By: /s/ Samir Gharib Samir Gharib President and Chief Financial Officer